Hib-DTP-hepatitis B vaccine - Heber Biotec/Center for Genetic Engineering and Biotechnology

Drug Profile

Hib-DTP-hepatitis B vaccine - Heber Biotec/Center for Genetic Engineering and Biotechnology

Alternative Names: Heberpenta 4+1; Heberpenta-L

Latest Information Update: 17 Dec 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Center for Genetic Engineering and Biotechnology
  • Developer Center for Genetic Engineering and Biotechnology; Heber Biotec
  • Class Haemophilus vaccines; Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Tetanus

Most Recent Events

  • 01 Dec 2013 Launched for Diphtheria, Haemophilus infections, Pertussis, Tetanus and Hepatitis B (prevention in infants and children) in Argentina, Ecuador, Uruguay and Venezuela before December 2013 (IM)
  • 01 Dec 2010 Launched for Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention in infants and children) in Cuba (IM; liquid premixed)
  • 10 Nov 2009 Phase-II clinical trials in Diphtheria, Tetanus, Pertussis, Haemophilus infections and Hepatitis B (prevention in infants and children) in Cuba (IM; liquid premixed)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top